Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2003
12/17/2003EP1226131B1 Isoxazolecarboxamide derivatives
12/17/2003EP1218380B1 Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP1189889B1 Compositions and methods for inhibiting cell death
12/17/2003EP1162970B1 Anti-inflammatory uses of manzamines
12/17/2003EP1157031B1 Oligomers substituted by phosphonic acid ester, phosphonic acid or carbaborane functions and the corresponding pna monomers
12/17/2003EP1150692B1 Use of hyaluronic acid or fragments thereof for the preparation of a medicament for regulating hematopoietic differentiation
12/17/2003EP1147121B1 Ketolide antibiotics
12/17/2003EP1112065B1 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose deivative
12/17/2003EP1109805B1 Inhibitors of bacterial nad synthetase
12/17/2003EP1109799B1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
12/17/2003EP1102781B1 New cofactors for methyltransferases
12/17/2003EP1100775B1 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same
12/17/2003EP1098878B1 Bispiperidines as antithrombotic agents
12/17/2003EP1093456B1 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents
12/17/2003EP1082302B1 A vla-4 inhibitor: omepupa-v
12/17/2003EP1066043B1 Materials for the treatment of conditions involving mast cells, basophils and eosinophils
12/17/2003EP1051392B1 Adamantanecarboximidamide derivatives and their use as nmda antagonists
12/17/2003EP1032370B1 Porous hydroxyapatite particles as carriers for drug substances
12/17/2003EP1023296B1 3-substituted pyrido 3',4':4,5] thieno 2,3-d] pyrimidine derivatives, and production and use of the same
12/17/2003EP1009420B1 Conjugates useful in the treatment of prostate cancer
12/17/2003EP1007074B1 Hypothalamus-specific polypeptides
12/17/2003EP1001943B1 Polyhydroxyalkylpyrazine derivatives, preparation and medicines containing them
12/17/2003EP1001752B1 Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals
12/17/2003EP1000047B1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring
12/17/2003EP0980241B1 Gelatine encapsulated solution dosage forms of sertraline
12/17/2003EP0974355B1 Water-soluble vitamin composition that provides excellent tablets and process for producing the same
12/17/2003EP0939624B1 Effervescent bisphosphonate formulation
12/17/2003EP0937075B1 New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.
12/17/2003EP0934276B1 Anthranilic acid derivatives as multi drug resistance modulators
12/17/2003EP0928196B1 Beta-glucan products and extraction processes from cereals
12/17/2003EP0902781B1 Preparation of (s)-decahydroisoquinoline-3-carboxylic acid t-butylamide
12/17/2003EP0900212B1 Chiral phenyldihydrofuranones as pde-iv inhibitors
12/17/2003EP0871625B1 Preparation of triazoles by organometallic addition to ketones and intermediates therefor
12/17/2003EP0852490B1 Emulsion formulations for the delivery of nucleic acids to cells
12/17/2003EP0831820B1 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
12/17/2003EP0641218B1 Use of angiotensin antagonist (at1) for reducing post myocardial infarct mobidity and mortality
12/17/2003EP0571387B1 A non-mitogenic competitive hgf antagonist
12/17/2003EP0554291B1 Treatment of non-inflammatory bowel disorders
12/17/2003CN1462310A Process for producing isomaltose and use thereof
12/17/2003CN1462275A Phosphonocephem compound
12/17/2003CN1462274A Triazolo-epothilones
12/17/2003CN1462273A Bicyclic heteroaromatic compounds
12/17/2003CN1462270A Imidazole derivatives or their salts
12/17/2003CN1462269A Fused azepine drivatives and their use as antidiuretic agents
12/17/2003CN1462268A Substituted cinnamic acid guanidides, method for the production thereof, their use as medicament, and medicine containing these compounds
12/17/2003CN1462197A Tumor treatment
12/17/2003CN1462193A Oral preparations
12/17/2003CN1462191A Treatment of ocute coronary syndrome with GLP-1
12/17/2003CN1462189A Midicial herbal compound for prevention and treatment of diabetes
12/17/2003CN1462188A Compositions for regulating desire for smoking
12/17/2003CN1462187A Analgesic/antiinflammatary patches for topical use
12/17/2003CN1462185A Improved transdermal therapeutic system for treatment of Parkinson's disese
12/17/2003CN1461806A Human leukemia related reverse transcript virus gene genome nucleic acid sequence and its application
12/17/2003CN1461754A Telerance starch made of starch of de-amylopectin by iso-anylase
12/17/2003CN1461656A Medicinal excipient-potassium alginate and its composition
12/17/2003CN1461644A Medicine for treating lung cancer-Bofeng capsule, and art for producing same
12/17/2003CN1461643A Water solution of ÔÇ£PenxiluoweiÔÇØ, and its prepn. method
12/17/2003CN1461642A Method for prepn. of clathrate of keto-brufen and beta-cydodextrin or its derivatives
12/17/2003CN1461641A Calcium supplementing agent and its prepn. method
12/17/2003CN1461640A Slow releasing injection contg. antiparasitic medicine
12/17/2003CN1131309C IL-6 mutein
12/17/2003CN1131241C Cross-linked hyaluronic acids and medical uses thereof
12/17/2003CN1131239C Compositions for treating or preventing prostatic cancer
12/17/2003CN1131238C 3-substituted-3-homo-1,3,5 (10)-estratriene derivatives
12/17/2003CN1131237C Usage of steroi saponin for preventing and curing senile dementia and new steroi saponin
12/17/2003CN1131235C 11'beta-halogen-7alpha-substd estratrienes, Preparation of Pharmaceutical preparation containing 11'beta'-halogen-7alpha-substd estratrienes
12/17/2003CN1131234C Antisense nuleic acid against protein kinase gene and its tumor-inhibiting function
12/17/2003CN1131233C Carbohydrate derivatives and their solid-phase synthesis
12/17/2003CN1131230C Tricyclic delta 3-piperidines as alpha 2-antagonists
12/17/2003CN1131229C Salt of naphthyridine carboxylic acid derivative
12/17/2003CN1131228C Benzo (5,6) cyclohepta (1,2-6) pyridine derivs. for inhibition of farnesy-protein transferase
12/17/2003CN1131226C Novel 1,2-amylic cycle disulfide, its preparation method and medicinal compositions containing same
12/17/2003CN1131225C Novel polyoxypropylenpolyoxyethylene vitamin E and preparation thereof
12/17/2003CN1131224C Luteolin and method for preparationg luteolin derivatives
12/17/2003CN1131222C Benzamide derivs and their use as APOB-100 secretion inhibitors
12/17/2003CN1131216C Condensed 1,2-indene dihydride and its salt for medicine its preparation method and application
12/17/2003CN1131215C Cyclic and heterocyclic n-substituted 'alpha'-iminoh-ydroxamic acid and carboxylic acids
12/17/2003CN1131214C Tetrahy droquimoline derivatives as EAA antagonists
12/17/2003CN1131212C Phenyl-and pyridinyl derivatives
12/17/2003CN1131211C Heteraryl diazacy cloa lkanes as cholinergic ligands at nicotinic acetylcholine receptors
12/17/2003CN1131203C Method for separating tramadol raceme
12/17/2003CN1131202C Calcium receptor-active compounds
12/17/2003CN1131067C Tinea pedis external used medicament
12/17/2003CN1131066C Application of radix scutellariae stem and leaf for preparing medicine for analgesia, anti-flammatory/and antipyretic
12/17/2003CN1131065C Medicine for treating hemipara lysis, obstruction of qi in the chest and cardialgia
12/17/2003CN1131060C Chinese medicine compound preparation treating fatty liver
12/17/2003CN1131052C Preparation method of medicated gargle wine for toothache
12/17/2003CN1131047C Ointment for treating spinal hyperosteogeny
12/17/2003CN1131046C Chinese medicine for treating baby pneumonia
12/17/2003CN1131042C Bee glue preparation for treating stomatocace and its compounding process
12/17/2003CN1131040C Application of double-stranded ribonucleic acid in preparing medicine for treating human coxsackie virus infection
12/17/2003CN1131039C Process for preparing kelamycin injection
12/17/2003CN1131038C Application of N-acetyl-D-amineglucose in preparing medicine to help treatment of perianal disease
12/17/2003CN1131037C Application of N-acetyl-Daminoglucose in preparing medicines to prevent and treat sexual disfunction
12/17/2003CN1131036C Application of N-acefyl-D-aminoglucose in preparing medicines to suppress by-effect of radiotherapy and chemicotherapy
12/17/2003CN1131035C Method for treating recongnitive dysfunction
12/17/2003CN1131034C Novel pharmaceutical composition
12/17/2003CN1131033C Anaesthetic formulation
12/17/2003CN1131032C Benzimidzole enteric coating preparation and preparing method thereof
1 ... 5242 5243 5244 5245 5246 5247 5248 5249 5250 5251 5252 5253 5254 5255 5256 5257 5258 5259 5260 5261 5262 ... 7860